
1. bioorg med chem lett. 2011 mar 1;21(5):1414-8. doi: 10.1016/j.bmcl.2011.01.021.
epub 2011 jan 11.

design novel cxcr4 antagonists potent inhibitors t-tropic (x4)
hiv-1 replication.

skerlj r(1), bridger g, mceachern e, harwig c, smith c, kaller a, veale d, yee h,
skupinska k, wauthy r, wang l, baird i, zhu y, burrage k, yang w, sartori m,
huskens d, de clercq e, schols d.

author information: 
(1)genzyme corp., waltham, 02451, usa. renato.skerlj@genzyme.com

a novel series cxcr4 antagonists identified based substantial
redesign amd070. compounds possessed potent anti-hiv-1 activity and
showed excellent pharmacokinetics rat dog.

copyright Â© 2011 elsevier ltd. rights reserved.

doi: 10.1016/j.bmcl.2011.01.021 
pmid: 21295470  [indexed medline]

